🚀 Partner with Pharmidex for Innovative Drug Discovery! 🌟
August 1, 2024
Pharmidex is seeking passionate partners to discover new medicines using cutting-edge in silico strategies. Whether you're identifying protein targets for existing drugs or screening compound libraries for potential hits, we're ready to collaborate and drive groundbreaking discoveries.
Our Expertise:
· Specialist expertise in computational, structural, and molecular biology
· Gold standard software (X-Ray Crystallography, Cryo-EM, molecular docking, 3D-Pharmacopohore determination)

Harness state-of-the-art software and computational power for all steps of in silico drug discovery development. Let's innovate together!
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
